[HTML][HTML] Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review

P Pachori, R Gothalwal, P Gandhi - Genes & diseases, 2019 - Elsevier
The emergence of antibiotic resistant bacteria in the healthcare is a serious concern. In the
Healthcare premises precisely intensive care unit are major sources of microbial diversity …

Prevalence of multidrug-resistant, extensively drug-resistant, and pandrug-resistant Pseudomonas aeruginosa from a tertiary level intensive care unit

JS Gill, S Arora, SP Khanna… - Journal of global …, 2016 - journals.lww.com
Background: Infection by Pseudomonas aeruginosa is common in the Intensive Care Unit
(ICU), leading to increased morbidity and mortality. The organism is classified into various …

Pseudomonas aeruginosa – a phenomenon of bacterial resistance

T Strateva, D Yordanov - Journal of medical microbiology, 2009 - microbiologyresearch.org
Pseudomonas aeruginosa is one of the leading nosocomial pathogens worldwide.
Nosocomial infections caused by this organism are often hard to treat because of both the …

Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance

C Liao, X Huang, Q Wang, D Yao, W Lu - Frontiers in cellular and …, 2022 - frontiersin.org
Pseudomonas aeruginosa is an opportunistic pathogen causing nosocomial infections in
severely ill and immunocompromised patients. Ubiquitously disseminated in the …

[HTML][HTML] Pseudomonas aeruginosa: an antibiotic resilient pathogen with environmental origin

P Laborda, F Sanz-García, S Hernando-Amado… - Current Opinion in …, 2021 - Elsevier
Highlights•P. aeruginosa is opportunistic pathogen with an environmental origin.•P.
aeruginosa presents low susceptibility to currently used antibiotics.•P. aeruginosa displays a …

[HTML][HTML] How to manage Pseudomonas aeruginosa infections

M Bassetti, A Vena, A Croxatto, E Righi, B Guery - Drugs in context, 2018 - ncbi.nlm.nih.gov
Infections with Pseudomonas aeruginosa have become a real concern in hospital-acquired
infections, especially in critically ill and immunocompromised patients. The major problem …

Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options

M Chatterjee, CP Anju, L Biswas, VA Kumar… - International Journal of …, 2016 - Elsevier
Pseudomonas aeruginosa is a leading cause of nosocomial infections and is responsible
for∼ 10% of all hospital-acquired infections worldwide. It continues to pose a therapeutic …

Pseudomonas aeruginosa: a clinical and genomics update

AC Pelegrin, M Palmieri, C Mirande… - FEMS Microbiology …, 2021 - academic.oup.com
Antimicrobial resistance (AMR) has become a global medical priority that needs urgent
resolution. Pseudomonas aeruginosa is a versatile, adaptable bacterial species with …

Prevalence of different virulence factors and their association with antimicrobial resistance among Pseudomonas aeruginosa clinical isolates from Egypt

EA Edward, MR El Shehawy, A Abouelfetouh… - BMC microbiology, 2023 - Springer
Background Emergence of multi-drug resistant Pseudomonas aeruginosa, coupled with the
pathogen's versatile virulence factors, lead to high morbidity and mortality rates. The current …

In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with …

M Riou, S Carbonnelle, L Avrain, N Mesaros… - International journal of …, 2010 - Elsevier
Pseudomonas aeruginosa causes severe nosocomial pneumonia in Intensive Care Unit
(ICU) patients, with an increased prevalence of multiresistant strains. We examined the …